INTRODUCTION {#SEC1}
============

Stem Cells (SCs) present a unique capacity for self-renewal and differentiation into other cell types. These features have made them the subject of intense research not only in fundamental cell and developmental biology ([@B1]--[@B3]), but also in a biomedical context in the fields of regenerative medicine ([@B4]--[@B6]), cancer progression and treatment ([@B7]), drug discovery and testing ([@B8],[@B9]) and modelling of human diseases ([@B8]--[@B10]).

While sharing the capacity for self-renewal and generation of differentiated progeny, a large variety of distinct SC types exist. In mammals, SCs can be classified according to their developmental structure or tissue of origin (embryonic versus adult SCs) as well as their potential to differentiate into one or many cell types. An accurate phenotypic classification of SC lineages, however, is a challenging task, particularly for closely related cell types. Commonly, the expression patterns of so-called marker genes have been used to define specific SC populations. Although this system offers a convenient approach for SC classification and purification, it has shortcomings as the obtained cell population may still show considerable heterogeneity ([@B11],[@B12]). One of the primary goals of SC research has, therefore, been to determine more comprehensive profiles of SCs for better identification and characterisation of individual lineages. For this purpose, genome-wide expression profiling techniques have been applied extensively. Numerous transcriptomics datasets have been generated for various SC types and deposited in public data repositories. In principle, this wealth of data should provide a compelling basis for the dissection of molecular processes underlying cellular identity and lineage. Moreover, the comparison of expression measurements from different experiments could help to identify more robust gene signatures and potential new marker genes. However, individual researchers seeking to explore available gene expression profiles across different SC lineages and experiments face a formidable task. Three major obstacles are prominent: (i) the massive amount of data; (ii) heterogeneity in original data processing and low quality datasets; and (iii) a limited number of ready-to-use and user-friendly analysis tools. Furthermore, it is not trivial for researchers to compare their own SC transcriptomics datasets with existing data in a comprehensive manner.

To help overcome these hurdles, we designed and implemented StemMapper, freely accessible at <http://stemmapper.sysbiolab.eu>. This resource is a manually curated database of gene expression data, holding information of a diverse range of SC and progenitor cell (PC) types for mouse and human. A main objective of StemMapper is to provide easy access to an integrated compendium of expression data collected from different transcriptomics experiments. StemMapper features (i) quality controlled data processed in a standardized manner; (ii) a clean and simple query interface; (iii) ability to integrate user-specific gene expression (.CEL) files into the analysis; (iv) intuitive visualization tools for gene expression landscape comparison; (v) interactive data analysis; and (vi) straightforward data retrieval.

Here, we briefly describe the data integrated in StemMapper, its pre-processing and curation procedure, how to explore gene expression data using the built-in analysis tools, and list the alternative methods by which information can be accessed and retrieved.

MATERIALS AND METHODS {#SEC2}
=====================

Data collection and dataset curation {#SEC2-1}
------------------------------------

StemMapper currently holds 798 mouse and 166 human transcriptomes, representing a comprehensive coverage of expression profiles for 51 types of murine SCs, PCs and their progeny, as well as 19 types of human SCs, PCs and their progeny ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Transcriptomic datasets for potential integration into StemMapper were collected from NCBI's Gene Expression Omnibus (GEO) ([@B13]). To identify relevant GEO data series, the following search criteria were used for the current version of StemMapper: (i) Organism: *Homo sapiens* OR *Mus musculus*; (ii) Platform: Affymetrix Mouse Genome 430 2.0 Array OR Affymetrix Human Genome U133 Plus 2.0 Array, and (iii) Description: 'stem' AND 'cell\*'. The particular microarray platforms were chosen based on their broad coverage of SC types and the standardized procedures for sample handling and data pre-processing that helps to improve comparability of independent measurements. Future versions of StemMapper will include additional transcriptomics platforms, as discussed below.

Each retrieved GEO data series was subjected to a detailed curation process. First, each GEO record was inspected to manually classify the samples according to tissue of origin and stem cell lineage. Relevant information regarding treatments, conditions, and (cell surface) markers used for sorting of profiled SC/PC populations was extracted from the GEO records. Extraneous records were removed, and the remaining ones were further processed by a quality control (QC) assessment using the automatic R pipeline AffymetrixQC ([@B14]) customized to run locally. Briefly, this pipeline controls for sample quality, signal quality, signal comparability and biases, and array correlation. All samples passing the QC were subsequently processed in a standardized way to enhance comparability and consistency of the integrated data, while reducing potential batch effects related to the study of origin. For this purpose, we created a custom implementation of frozen RMA (fRMA) normalization procedure using the fRMA Tools package ([@B15],[@B16]). The frozen parameter vectors were calculated on the basis of the data contained in StemMapper\'s database. The training data included a diverse set of batches, which were in our case GEO series (GSE) and were selected to cover a broad range of SC types and experimental conditions (e.g. control, treatment and time). A batch size of three microarrays was chosen for the Affymetrix mouse genome platform and a batch size of four microarrays for the Affymetrix human genome platform. In total, 82 batches for mouse (246 arrays) and 17 batches for human (68 arrays) were used to derive the fRMA parameters.

Finally, Principal Component Analysis (PCA) was applied to detect outlier samples, i.e. samples that either segregate outside the major clusters of the same cell lineage, or fall within clusters of other cell types. In this manner, we sought to remove potentially mis-annotated samples that could compromise downstream analyses and the overall quality of data integrated into StemMapper.

Implementation {#SEC2-2}
--------------

StemMapper\'s database was implemented using MySQL. The web interface was developed using JavaScript and JavaServer Faces (JSF) 2.1, a Java-based framework for the development of user interfaces. The PrimeFaces library was used to extend the functionalities of JSF's standard core and tag libraries.

Gene expression analyses, namely the PCA, the generation of heatmaps and processing of user data (.CEL file), are carried out by using R packages from the R/Bioconductor platform. User submitted data are processed using the Bioconductor packages affy ([@B17]) and frma ([@B15]). Communication between R and the Java components is provided through Rserver. The MySQL database is accessed via the Hibernate library. Plots and heatmaps are drawn using the plotly.js JavaScript charting library.

USER INTERFACE {#SEC3}
==============

StemMapper features a user-friendly query interface and a set of interactive visualization and analysis tools that can provide a rapid overview of the data and can serve as a basis for follow-up investigations. They enable the user to: (i) visualize overall gene expression differences between SC types; (ii) compare the expression levels of particular genes of interest across different SC lineages and conditions; (iii) query and download curated gene expression data, selected based on gene identity, cell type, or both; and (iv) upload gene expression files for direct analysis and comparison with the data integrated in the database.

The query interface is accessible via the *Analysis* tab. The query can be specified and executed in four steps: (1) select datasets; (2) select marker genes; (3) add genes of interest; and (4) analysis (query panel from Figure [1](#F1){ref-type="fig"}). Question mark buttons are available for each step, containing brief instructions on how to proceed with the selections. In the first step, the user selects the appropriate microarray platform (mouse or human data) and the datasets pertaining to the cell lineage(s) of interest. The second and third steps consist of selecting the genes of interest, for which the expression values will be retrieved from the database to be analysed and visually inspected. To guide the user, we have pre-compiled lists of established marker genes (derived from <https://discovery.lifemapsc.com/in-vivo-development/organ-tissues>) that can be (optionally) selected in step 2. Additional genes of interest can be directly input in the text box, or searched for (by gene symbol) in the search box enclosed in step 3. Genes can be also removed by deleting their identifiers in the textbox. This enables easy adjustment of the pre-compiled gene lists. In the fourth step, users are given the option to upload their own gene expression (.CEL) file to be processed and analyzed together with the information from the database. Finally, the query can be executed by pressing the 'Submit' button.

![StemMapper workflow using a set of genes associated with the differentiation of neural precursor cells into astrocytes. Query panel (steps 1--4): After selecting all transcriptomic profiles for mouse (step 1), the 18 genes of interest were used as input (step 3) without the optional selection of pre-compiled marker genes (step 2), and the query was executed (step 4). Analysis panel (steps 5--7): Inspection of the produced heatmap (step 5) shows that Gfap is expressed specifically in samples of the neural lineages (highlighted with a green box). Calculation of the correlation with Gfap leads to the identification of 40 genes with strongly correlated or anti-correlated expression patterns (step 6). These genes were then used as new input together with Gfap (step 7). In the newly generated heatmap (step 8) seven genes (highlighted with a red box) displayed high expression in samples of the neural lineage and weak or no expression in most other samples similar to Gfap (indicated by a red star). The PCA plot based on the 40 input genes shows a clear separation of samples of the neural lineage including olfactory (bulb neural stem) cells (step 9). Researchers can then download the processed data to perform follow-up analyses.](gkx921fig1){#F1}

Once the queried data is retrieved and processed, two main tabs are generated: *Heatmaps* and *PCA Plot* containing interactive plots for these visualizations, allowing the user to access detailed gene-centered or cell type-centered information. On the *Heatmaps* page, the retrieved expression data for the selected genes and cell types are visualised and the samples are hierarchically clustered. Subsequently, the user can inspect the fRMA processed expression in the *Normalized Expression* sub-tab, or ranked expression values ranging from zero to one in the *Percentile Expression* sub-tab. The latter values are defined by the percentiles of a gene\'s expression with respect to its expression in all samples included in StemMapper. Thus, it provides a means for assessing how strongly a gene is expressed in a given sample compared to the expression observed in all other samples in StemMapper. The displays are interactive, allowing the user to easily inspect the expression values for genes and samples by moving the pointer over the heatmaps. Additionally, it is possible to zoom into the heatmaps. Clicking on a particular gene track creates a new window that lists summary information related to the gene\'s expression in the chosen cell types, namely, the median, minimum and maximum expression values, as well as the preferential expression measure (PEM, [@B18]). In our case, the PEM of a gene for a cell type is defined as the difference of its average log~2~-transformed expression in the given cell type and its average log~2~-transformed expression in all cell types included in the analysis. Thus, PEM can be used to assess the specificity of expression of a gene in a particular cell type. Similarly, clicking on the leaves of the dendrogram opens a window with details about the corresponding sample, together with relevant GEO links. The new window also provides the possibility to download the expression data for all genes from the selected sample.

Since a common task in transcriptomics is the identification of co-regulated genes, an option for correlation analysis is implemented in StemMapper. The calculation of the Pearson correlation between the expression values of a selected gene and the expression values for all other genes in the selected samples can be executed via the corresponding action buttons. A new window subsequently displays a table with calculated correlation coefficients and respective p-values. The rows of the table can be ordered by clicking on the column header.

The *PCA plot* page provides the results of a PCA using the samples' expression profiles based on the queried genes in an interactive manner. Hovering over the points on the plot displays the label of the corresponding samples. Clicking on a data point produces a brief description of the sample together with its GEO links, and the possibility to download (in tab separated format) the expression data for all genes from that sample. Importantly, to facilitate the detection of relevant clusters of samples in the data, StemMapper allows for alternative colouring of the data points based on specific sample features. For instance, data points in the PCA plot can be coloured according to the SC type, tissue of origin, differentiation status, (surface) markers or treatment types. Both the expression heatmaps and the PCA plot can be exported as PNG files.

WORKFLOW EXAMPLE {#SEC4}
================

To illustrate the utility and potential application of StemMapper, we describe the workflow of an exploratory data analysis using our database. Here, our aim is to find novel candidate marker genes from the analysis of a set of established genes associated with the differentiation of neural precursor cells (NPCs) into astrocytes (Figure [1](#F1){ref-type="fig"}).

Astrocyte differentiation from NPCs {#SEC4-1}
-----------------------------------

Astrocytes are the most abundant cell type in the mammalian brain. Accordingly, to understand brain development and function, the elucidation of astrocytogenesis is of utmost importance ([@B19]). Astrocytes derive from NPCs that can self-renew, or differentiate into neurons, astrocytes or oligodendrocytes. These lineage commitments are typically coordinated by the activity of lineage-specific transcription factors, which in turn are known to be tightly regulated by signalling molecules, such as cytokines ([@B20]).

Glial fibrillary acidic protein (Gfap) is considered an astrocyte-specific gene and has been widely used in the study of astrocytogenesis ([@B20]). Ito and colleagues set out to discover genes associated with Gfap during astrocyte differentiation. Using genome-wide enhanced circular chromosomal conformation capture (e4C), they found 18 genes to be specifically associated with Gfap and expressed in NPC-derived astrocytes ([@B20]).

Finding putative novel astrocyte marker genes (Figure [1](#F1){ref-type="fig"}) {#SEC4-2}
-------------------------------------------------------------------------------

Steps 1--4. Using StemMapper to prioritize the study of these novel putative neural marker genes we investigated the expression pattern of Gfap in all cell types, together with the aforementioned 18 genes: Osmr, Ogn, S100a6, Itih5, Glis3, Fst, Rdh10, Ecrg4, Rnf13, A2m, Rsph9, Galntl1, Rad23b, Tgfbr2, Clcn3, Spnb2, Ppp1r15a and Gab1 in all available lineages (Figure [1](#F1){ref-type="fig"}).

Step 5. Visual inspection of the Normalized Expression Heatmap reveals that, of all the input genes, Gfap shows the most neuron-specific signature, i.e. Gfap is highly expressed specifically in neural lineages corroborated by the large PEM of 6.2 for murine brain samples of the dorsal subventricular zone (as displayed when clicking on Gfap\'s gene track).

Steps 6--7. For detection of other potential astrocyte markers, we applied the correlation analysis implemented in StemMapper to find genes correlated or anti-correlated with Gfap. The top and bottom 20 genes served then as new input into StemMapper.

Steps 8--9. Examination of the PCA plot shows that the 40 selected genes clearly separates neural cell lineage types (including olfactory bulb stem cells) from other lineages, indicating a strong discriminative potential.

Subsequent inspection of the corresponding heatmap revealed seven genes with expression patterns that were particularly similar to the one of Gfap. Of those, three genes have annotated functions: the well-known CNS-related gene Slc1a2 (Solute carrier family 1 (glial high affinity glutamate transporter), member 2), Itih3 (Inter-alpha trypsin inhibitor, heavy chain 3), and Lsamp (Limbic system-associated membrane protein). More interestingly, we identified four promising candidate marker genes without current functional annotation: Gm20081 (Predicted gene 20081), Morn5 (MORN repeat containing 5), A830039N20Rik (RIKEN cDNA A830039N20 gene), and Fam216b (Family with sequence similarity 216, member B). The latter genes represent attractive objects for further experimental studies in the context of astrocytogenesis given their specific expression in the neural lineage.

The user can subsequently choose to retrieve the relevant data for follow-up analyses, either directly by pressing the 'Download' button presented for each sample (providing the standardized processed data), or by following the GEO links to obtain the raw data from the source.

CONCLUSIONS AND FUTURE DIRECTIONS {#SEC5}
=================================

SCs have been the focus of intense biomedical research leading to the generation of a vast amount of gene expression data that can be overwhelming for researchers. The salient need to facilitate exploration of the accumulated data has led to the development of StemMapper.

With its described features, StemMapper further complements and extends the repertoire of existing online resources for gene expression in SCs. These include tools such as ImmGen Gene Skyline ([@B21]), Codex ([@B22]), Gene Expression Commons ([@B23]), Expression Atlas ([@B24]) and Stemformatics ([@B25]), which provide - similarly to StemMapper - access to expression data for a wide range of cell types. Alternatively, online resources have been established to study the gene expression in particular cell lineages, such as, BloodSpot ([@B26]), HaemAtlas ([@B27]) and Differentiation Map ([@B28]) for hematopoietic cells, or for specific types of stem cells such as StemCellDB ([@B29]) for human embryonic stem cells.

StemMapper\'s strength lies in its comprehensive coverage of SC types, allowing the user to easily compare gene expression profiles across a wide range of SC lineages. StemMapper features a collection of quality-controlled and manually curated data, and can function as a 'one stop' resource where researchers can easily check previously reported expression values for their genes of interest, while comparing them across different SC lineages. Users can additionally upload their own gene expression (.CEL) files to visualize their measurements together with previously reported ones, a feature that, as far as we know, is unique to StemMapper.

Like with any other computational tool in biology, certain limitations exist for StemMapper. One of the most prominent is the undertaken selection of a particular transcriptomics platform, i.e. in our case Affymetrix GeneChips, as primary source for gene expression data. While this restriction is likely to enhance the comparability of measurements across different experiments, it led to the exclusion of data generated by other relevant technologies such as RNA-seq. For a future version, we therefore plan to integrate SC expression profiles from other transcriptomics platforms in StemMapper. Although cross-platform data integration is challenging, recent analysis indicate that such integration through appropriate data transformation is feasible ([@B30]). This extension of StemMapper will also enable the user to upload transcriptomics data generated by different microarray or sequencing technologies.

Furthermore, we envision the inclusion of single cell expression profiles, as these type of data provide a more precise view of the molecular heterogeneity of SCs which might be masked by the analysis of cell populations ([@B31]). In fact, it should be noted that many of the included transcriptomics data sets for SCs do not represent expression profiles of pure cell populations, but rather of cell populations enriched by a particular SC type. For instance, it has been estimated that many purification strategies for hematopoietic SCs only reach a purity rate of up to 50%, despite haematopoiesis being one of the most intensively studied models in SC biology ([@B12]). Another enhancement of StemMapper will be the inclusion of marker genes that are more discriminative on transcript level. At the moment, we provide pre-compiled lists of markers that are at least partially based on observed protein abundance and thus might not be optimal for classification of transcriptomic data. Finally, we plan to link StemMapper to other computational resources developed in our group for SC biology analysis, i.e. StemCellNet ([@B32]) and StemChecker ([@B33]) enabling the user to conduct a multitude of complementary *in silico* analyses within the domain of SC biology.

Supplementary Material
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